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ABSTRACT
IMPACT OF MACULAR PIGMENT OPTICAL DENSITY ON PHOTOPHOBIA
THRESHOLD
by
Adam J. Wenzel
University o f New Hampshire, September, 2004

Two carotenoids, lutein and zeaxanthin, accumulate in the central retina where
they are collectively referred to as macular pigment (MP). By absorbing shortwavelength light, MP may attenuate photophobia (PP)—visual discomfort induced by
normal light exposure— for targets composed of short-wavelength light. The aim of this
study was twofold: first, to investigate a possible relationship between integrated macular
pigment optical density (MPOD) and PP thresholds for short-wavelength targets relative
to mid- to long-wavelength targets; and second, to measure changes in PP thresholds after
increasing MP with lutein supplements.
MPOD was measured psychophysically at 20', 30', 60' and 120' eccentricity with
a Macular Metrics® densitometer. Each subject’s MPOD profile was fit with a Gaussian
and Lorentzian function and the area under the curve was calculated to yield an integrated
Gaussian MPOD (iGMPOD) or integrated Lorentzian MPOD (iLMPOD). PP thresholds
for two foveal and two parafoveal, 8.2-degree targets were measured using a Maxwellianview optical system. At both loci, a scaling technique was used to measure subjects’
level o f discomfort for a short-wavelength broadband (blue) light, which was strongly
absorbed by MP, and a mid- to long-wavelength broadband (orange) light, which was not
absorbed my MP. For both eccentricities, the log relative energy necessary to induce PP
for the blue target was subtracted from the log relative energy necessary for the orange
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target. The foveal value was then subtracted from the parafoveal value to yield a PP
ratio. PP ratios and iGMPOD and iLMPOD were calculated for ten subjects. Repeated
measures were obtained for four of these subjects after six weeks and twelve weeks of
consuming 60mg of lutein ester supplements per day.
PP ratios were positively correlated with iGMPOD (r=0.830, p=0.002) and
iLMPOD (r=0.775, p=0.008). According to a subjects-by-trials design, both iGMPOD
(F=9.12, p=0.015) and iLMPOD (F=17.35, p=0.003) significantly increased from
baseline. Significant increases in integrated MPOD corresponded to significant increases
in PP ratio (F=10.41, p=0.036).
The results suggest that MPOD may influence the amount of short-wavelength
light necessary to elicit PP. Further, PP thresholds for short-wavelength lights can be
increased by augmenting MPOD with lutein supplementation.
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CHAPTER I

RETINAL CAROTENOIDS

Carotenoids are a class of naturally derived pigments synthesized by various
plants and protists. The basic structure of all carotenoids is a string of isoprene units.
The majority of identified carotenoids have a six-carbon ring at each end of a carbon
chain, which may include one or more oxygen groups. If the carbon ring contains
oxygen, the carotenoid is referred to as a xanthophyll (e.g., lutein and zeaxanthin),
otherwise it is called a carotene (e.g., p-carotene).
In plant systems, carotenoids appear to be synthesized to protect the organism via
two physiological reactions. First, carotenoids’ chain of conjugated double-bonds allows
them to transfer energy from singlet oxygen and other free radical species, effectively
quenching these noxious species. Second, carotenoids absorb light in the potentially
harmful, short-wavelength (SW) region of the spectrum and dissipate the energy as heat.
Carotenoids consumed in the diet may play these same beneficial roles in humans and
other animals. In fact, epidemiology studies have repeatedly found correlations between
carotenoid rich diets and good health. Specifically, carotenoid intake has been linked
with a lower risk for atherosclerosis (Dwyer et al., 2001; Gale et al., 2001) as well as
various types of cancers, such as prostate cancer (Lindsey 2002; Miller et al., 2002),
breast cancer (Johnson, 2000) and ovarian cancer (Huncharek et al., 2001). Dietary
carotenoids may also reduce one’s risk of developing cataract and age-related macular
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degeneration (AMD; Moeller et al., 2000), two leading causes o f blindness (Robinson et
al., 1997; AREDS, 2000).
Two carotenoids are primarily associated with preventing cataractogenesis and
AMD, lutein and zeaxanthin. These two plant pigments are found in a variety of fruits
and green, leafy vegetables commonly consumed in the human diet (Khachik et al.,
1992a; 1992b; Sommerburg et al., 1998). The absorption of lutein and zeaxanthin occurs
in the duodenum, where the carotenoids are released from their food matrices and
incorporated into micelles. Some o f these micelles may transfer the carotenoids to
mucosal cells, via passive diffusion, whereas other carotenoid-containing micelles are
unabsorbed (Parker, 1996). After entering the enterocyte, lutein and zeaxanthin are
incorporated into chylomicra and then released into the blood stream. The carotenoid
concentration in chylomicra peaks approximately four to eight hours after intake (Yeum
& Russell, 2002). Circulating chylomicra are degraded by lipoprotein lipase and the
chylomicron remnants are collected by the liver. In the liver, carotenoids are repackaged
within lipoproteins. Some carotenoids, like P-carotene, are predominately distributed in
low-density lipoproteins (LDL), whereas lutein and zeaxanthin are distributed evenly
between LDL and high-density lipoproteins (HDL; Yeum & Russell, 2002). The
carotenoid concentration in lipoproteins peaks approximately 16 to 48 hours after
ingestion (Erdman et al., 1993).
The absorption, or bioavailability, of carotenoids is influenced by several factors
(see van het H of et al., 2000). For example, dietary fat must be consumed concurrently
with carotenoids in order to stimulate micelle formation. In the absence of dietary fat,
carotenoid absorption may be as low as 5%, whereas a small amount of fat may increase

2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

absorption to approximately 45% (Ribaya-Mercado, 2002). Unlike other carotenoids that
may be optimally absorbed when consumed with a limited amount of fat, one study
reported that lutein absorption was significantly greater in individuals who consumed a
lutein supplement with 34.4g of fat daily for seven-days, compared to individuals who
consumed the lutein with 3g of fat (Roodenburg et al., 2000). Another factor that affects
the absorption o f carotenoids is the food matrix containing the carotenoid. Generally,
absorption of carotenoids is greater when they are suspended in an oil solution (i.e.,
supplements), as opposed to raw vegetables (van het Hof et al., 1999). Processing of raw
vegetables, on the other hand, may increase the bioavailability of some carotenoids.
Castenmiller et al. (1999) showed that processing raw spinach improved the
bioavailability o f p-carotene, but had little effect on lutein absorption. The absorption of
carotenoids is also affected by the interaction or competition between carotenoids in the
lumen and enterocytes. A number of researchers has shown that coincident consumption
of lutein with other carotenoids may impair lutein absorption (see van den Berg, 1999).
Tyssandier et al. (2002), for example, reported that chylomicron lutein levels were
diminished when lutein (from spinach) was consumed with lycopene supplements.
Conversely, Gartner et al. (1996) showed that after consuming a single dose of
Betatene™—a natural extract containing lutein, zeaxanthin, a-carotene and p-carotene—
the chylomicron distribution of lutein was fourteen times greater than its relative
concentration in the supplement; the zeaxanthin distribution was four times greater than
its relative concentration.
Carotenoids are transported through the body in lipoproteins, and via unrealized
mechanisms, deposited in lipophilic tissues such as adipose tissue and various immune

3
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organs (Olsen, 1984). Lutein and zeaxanthin, to the exclusion of other carotenoids, cross
the blood-retinal barrier and are deposited in the inner plexiform (i.e., ganglion dendrites
and bipolar cell extensions) and photoreceptor-axonal layers (Snodderly et al., 1984).
Although the exact mechanisms mediating this retinal accumulation are unknown,
Bernstein et al. (1997) suggested that specific lutein and zeaxanthin retinal binding
proteins, perhaps tubulin, may be responsible.
Lutein and zeaxanthin accumulate throughout the entire human retina
(Handelman et al., 1988). Using high-performance liquid chromatography, researchers
have estimated that the total retinal concentrations of lutein and zeaxanthin are between 4
and 145ng, with lutein accounting for approximately two-thirds of the combined tissue
concentration (Bone et al., 1988; Rapp et al., 2000). These carotenoids, however, are not
uniformly distributed in the retina. The aggregate concentration of both carotenoids is
greatest in the macular region, hence they are collectively called the macular pigment
(MP). According to Bone et al. (1988), who measured retinal lutein and zeaxanthin
concentrations between 0mm and 12.2mm from the foveal center, over 50 percent of the
retina’s macular carotenoids accumulate within one-degree (« 0.33mm) of the central
point. Lutein and zeaxanthin have two different concentration gradients. In the fovea,
the concentration of zeaxanthin exceeds that of lutein at a ratio of about 3:1 (Landrum et
al., 1999). In contrast, lutein is the dominant carotenoid in the peripheral retina,
accounting for two-thirds o f the total concentration. Edge et al. (1997) suggested that the
higher concentration of zeaxanthin relative to lutein in the central retina was due to its
greater antioxidant capacity. Other researchers have noted the obvious correlation
between the distribution of photoreceptors and the differing concentration gradients of

4
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lutein and zeaxanthin (Eisner et al., 1998; Sommerburg et al., 1999). Although both of
these hypotheses may be correct, they cannot completely account for the high degree of
variance in MP among individuals.
In the last fifteen years, more than thirty investigations have reported the mean
macular pigment optical density (MPOD) of various cohorts. The diverse assessment
techniques and stimulus parameters make meta-analytical estimates o f a population
average difficult. However, for twelve studies that employed similar assessment
methods, the mean MPOD (at 30 minutes of retinal eccentricity) of approximately 1,200
total subjects ranged between about 0.20 and 0.45. Data tables listed in two of these
studies showed that MPOD ranged between 0.01 and 0.5 in one study (Cuilla et al.,
2001b), and 0.0 and 0.94 in the other study (Hammond et al., 1997b). Despite the
unknown sources o f variance, Hammond and his colleagues, in a series of studies,
discovered three factors that may contribute to between-subject variability. One, the
greater light transmission of blue and gray irises, compared to dark irises, may represent
increased photodegradation of retinal lutein and zeaxanthin, in that individuals with lightcolored irises tend to have lower MPOD than individuals with dark irises (Hammond et
al., 1996b). In their study, the mean MPOD for 38 individuals with blue or gray irises
was 0.25, whereas the mean MPOD of 31 subjects with brown or black irises was 0.38 (p
< 0.01). Similar findings were observed in recent large-scale studies (Hammond &
Caruso-Avery, 2000; Cuilla et al., 2001a). Two, cigarette smoking may affect MPOD via
depleting available body stores of lutein and zeaxanthin or by increasing pro-oxidant
activity in the retina (Hammond et al., 1996c). These researchers found that, on average,
smokers had approximately half the MPOD of nonsmokers, 0.16 versus 0.34. Three,

5
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males tend to have higher MPOD than females (Hammond et al., 1996a). In that over 75
percent o f the body’s supply o f carotenoids are found in adipose tissue (Olsen, 1984), it
may be that females’ greater adiposity provides additional binding sites for carotenoids
(Su et al., 1998), resulting in less available lutein and zeaxanthin. That is, adipose tissue
may compete with the retina for carotenoids. It follows, then, that both males and
females with high amounts of adipose tissue might have lower MPOD. To wit,
Hammond et al., (2002) reported that obese individuals in their sample had significantly
lower MPOD than individuals with a BMI (body mass index) less than 29. Although
these factors identified by Hammond and colleagues may impact MPOD, several studies
have found contrary relationships. For example, in a study by Johnson et al., (2000),
females had significantly higher MPOD, despite their greater adiposity. In another study
by Beatty et al., (2001), there was no relationship between MPOD and either smoking
status or iris color. Nonetheless, it is interesting to note that the factors associated with
lower MPOD in the Hammond studies are also correlated with greater risk for developing
AMD.

6
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CHAPTER II

AGE-RELATED MACULAR DEGENERATION

AMD is the leading cause of irreversible legal blindness among the aged
population in the United States (National Advisory Eye Council, 1998). About twentypercent o f the population over the age of 60 have an early form of AMD called agerelated maculopathy (ARM; Klein et al., 1992; Cruickshanks et al., 1997), and between
five and eight-percent (six to ten-million Americans) have developed macular
degeneration (Beatty et al., 1999; la Cour et al., 2002). The hallmark o f AMD
pathophysiology is the accumulation of extracellular debris between the retinal pigment
epithelium (RPE) and Bruch’s membrane. The extracellular debris, called drusen,
consists of various cellular materials (e.g., unphagocytized disc membranes) thought to
be excreted by dysfunctional RPE cells (Hogan, 1972). As extracellular deposits
accumulate, RPE cells are stretched, depigmented and may eventually die, ultimately
resulting in photoreceptor necrosis (Young, 1987). Drusen formation occurs with age,
with most individuals over the age of 50 having drusen in at least one eye (Fine et al.,
2000). A few small (< 64pm), yellow drusen with demarcated borders, so called “hard”
drusen, are usually asymptomatic and not a strong risk factor for AMD. In the Beaver
Dam Eye Study, for example, only one individual with exclusively hard drusen
developed AMD (Klein et al., 1997). In contrast, “soft” drusen are large (> 64pm), pale
yellow, have poorly defined boundaries, and are a potential risk factor for AMD (Zarbin,
1998). When the number or size of drusen significantly impair central vision, often a
7
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visual acuity o f 20/200 or worse, the individual is said to have atrophic (dry) AMD. In
15% o f individuals with dry AMD, a more devastating loss of vision occurs when new
choroidal blood vessels grow and penetrate the weakened Bruch’s membrane (Goldsmith,
2003). These fragile blood vessels often hemorrhage, resulting in extensive
photoreceptor death. This latter form o f AMD is called “wet” or exudative AMD.
A number of risk factors for ARM and AMD have been identified in recent
studies. In addition to genetic susceptibility (Zarbin, 1998) and age (Beatty et la., 2001),
some potential risk factors for AMD include: light-colored irises (Sandberg et al., 1994;
Pratt, 1999), light exposure (Young, 1988; van der Hagen et al., 1993), female sex
(Cruickshanks et al., 1993; la Cour et al., 2002), BMI (Schaumberg et al., 2001) and
cigarette smoking (Seddon et al., 1996; Evans, 2001). Another important factor that
receives a great deal o f attention is diet. Several studies have found positive correlations
between AMD and fat consumption (Cho et al., 2001), and inverse correlations between
macular insult and carotenoid intake (Snodderly, 1995; Mares-Perlman et al., 2001). For
example, Snellen et al. (2002) showed that the prevalence of AMD was almost twice as
high in individuals who consumed a low-lutein diet, compared to individuals with a lutein
rich diet. Given the similarity between the factors correlated with low MPOD and the
risk factors associated with AMD, as well as the possible inverse relationship between
dietary carotenoid intake and macular damage, numerous researchers have postulated that
the MP may protect the retina.

8
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CHAPTER III

PROTECTIVE ROLE OF MACULAR PIGMENT

The macular carotenoids may protect the retina and contiguous tissues via the
same mechanisms observed in plant systems. One such way in which retinal lutein and
zeaxanthin may afford protection is via their ability to quench free radicals. Free radicals
are highly unstable molecules due to an unpaired electron in their outermost orbit. To
become stable, free radicals must capture an electron from another molecule, in turn,
producing another unstable molecule. This initial process can trigger a chain of such
reactions, as unstable molecules steal electrons from adjacent molecules—the outcome
often being damage to the involved particles. Several oxidation products of lutein and
zeaxanthin were discovered in donor retinae by Khachik et al. (1997), suggesting that the
macular carotenoids may interact and possibly quench free radicals in the retina.
Free radicals are generated throughout the body, but the presence o f high oxygen
content and focused SW light make the posterior ocular tissues particularly prone to the
generation of these reactive species. For example, lipofuscin, the metabolic byproducts
that accumulate in RPE cells with age, are photogenerators of oxygen radicals (Gaillard
et al., 1995; Bonnel et al., 2003), perhaps the most deleterious free radical species (van
der Hagen et al., 1993). Oxygenated radicals, such as hydroxyl radicals and hydrogen
peroxide species, are often used in in vitro analyses to estimate carotenoids’ antioxidant
efficacy. In short, researchers can determine a carotenoid’s relative antioxidant capacity

9
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by measuring the amount of light energy passing through a solution containing free
radicals and a specific carotenoid. As carotenoids bind with free radicals and share
electrons, they are degraded, resulting in less available pigment to absorb light.
Consequently, more light energy passes through the solution. For example, Woodall et
al. (1997b) found that in a solution containing peroxyl radicals, there was about a thirtypercent increase in both zeaxanthin’s and lutein’s transmittance at A.max after ten minutes
of incubation. In other words, almost thirty percent of lutein and zeaxanthin
concentrations were degraded in ten minutes. In a solution containing hydrogen
peroxide, these same researchers found that after five minutes, a little over thirty percent
of the total lutein concentration was degraded, and almost sixty-five percent of the
zeaxanthin concentration was depleted. This suggests that in the presence of hydrogen
peroxide, zeaxanthin may be a more effective antioxidant than lutein. Compared to other
carotenoids like P-carotene and lycopene, lutein and zeaxanthin have much slower
degradation rates in the presence of free radicals (Mortensen & Skibsted, 1997a; 1997b;
Woodall et al., 1997a), suggesting that they are less effective antioxidants. In turn, the
rapid free radical degradation or photo-bleaching of other carotenoids (e.g., lycopene)
might be the basis for their absence in the retina (Siems et al., 1999). However, other
carotenoids, like astaxanthin are more photo-stable than lutein and zeaxanthin, but less
effective as antioxidants. It seems, then, that lutein and zeaxanthin’s presence in the
retina represents an evolutionary compromise between antioxidant effectiveness and
photo-stability.
A second way in which MP may protect the retina is via screening SW light. The
absorption spectrum o f MP resembles a mesokurtic bell-curve, ranging between 410nm

10
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Figure 1: Absorption spectrum o f macular pigment
measured psychophysically by Wyszecki and Stiles
(1982).

approximately hundred times
less energy is needed at shorter

wavelengths (e.g., 440nm) to produce retinal insult, compared to longer ones (e.g.,
590nm). The elevated damage potential of SW light has also been noted by other
investigators (Ruffolo et al., 1984). The link between M P’s absorption spectrum and the
greater ability of SW light to cause damage seems obvious; MP may absorb potentially
harmful SW energy and dissipate it as heat, attenuating the amount of light energy
reaching the photoreceptors and supportive tissues. Thus, the combined functionality of
retinal lutein and zeaxanthin—a SW filter and antioxidant—may protect the macula from
light-induced insult (Snodderly, 1995; Pratt, 1999), and thereby sustain visual sensitivity
(Hammond et al., 1998).
In addition to protecting the retina against light damage, the filtration effects of
MP may help to improve visual acuity. Wooten and Hammond (2002) referred to this
possibility as the acuity hypothesis. The focusing elements of the human eye (lens and
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cornea) inherently produce longitudinal chromatic aberration, such that an emmotropic
eye focused on a middle-wavelength (MW) target will bring SW light to a focus anterior
to the retina (myopic), and long-wavelength (LW) light to a focus posterior to the retina
(hyperopic). This effect is most pronounced for SW light, exceeding -1.0 diopters for
wavelengths below 470nm (Wyszecki & Stiles, 1982). The consequences of chromatic
aberration on normal viewing conditions are often unnoticed, if not compensated for by
the visual system (i.e., down-regulating the response of the short-wave system). Only
under experimental conditions are the effects o f chromatic aberration apparent. For
example, subjects report the presence of a “violet” penumbra when viewing a broad-band
target (Hammond et al., 2001). Perhaps the perceptual intensity o f this SW fringe is
attenuated by the MP. Indeed, Reading and Weale (1974) calculated that the filtration of
SW light by MP should lessen the appearance of chromatic distortion. Although there is
little empirical evidence to suggest that MP may improve acuity via attenuating
chromatic aberration, several studies have reported increased visual function in
individuals with macular disease after intervention with spinach (Richer, 1999) and lutein
supplements (Dagnelie et al., 2000; Olmedilla et al., 2001).

.

The SW light filtration o f MP may also impact other conditions involving light
exposure. For example, Mesri and Dellepiane (1991) investigated the ability o f various
filters to mitigate the photoconvulsive response in patients with photosensitive epilepsy.
They found that SW absorbing filters could lessen or eliminate photoconvulsive
responses, whereas filters had little effect. Perhaps the filtering properties of MP could
impact patients’ thresholds for photoconvulsive responses, such that increased MPOD
could improve the quality of life for individuals with photosensitive epilepsy.
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CHAPTER IV

PHOTOPHOBIA

MP may also influence the magnitude of discomfort associated with photophobia
(PP)— a condition characterized by the exacerbation or generation of pain or discomfort
as a consequence o f normal light exposure. Although all individuals have likely
experienced an acute episode of PP, or dazzling glare (Vos, 2003), as they entered a
bright environment after prolonged exposure to dark surroundings (e.g., exiting a movie
theater on a sunny day), some individuals suffer from chronic light-induced pain. For
example, patients with neurological disorders, such as trigeminal neuralgia (Wolff, 1963),
and individuals suffering from eye diseases, like conjunctivitis, retinitis pigmentosa, and
AMD (Lebensohn, 1934; 1951; Gawande et al., 1989; Bacotti, 2001), often report
persistent hyper-sensitivity to light and periods of PP as symptoms of their condition. PP
also appears to accompany migraine headaches (Drummond, 1997; Vanagaite-Vingen &
Stovner, 1998; Muelleners et al., 2001), and m aybe more common among females
(Krymchantowski & Moreira, 2001). It should be noted that PP is a clinical term, lacking
a standardized operational definition, and is sometimes referred to as photoaversion or
discomfort glare in non-clinical literature.
The etiology o f visual pain associated with extreme light exposure (e.g., snow
blindness) is usually the result of UV light induced damage to the corneal epithelium.
Under normal light exposure, however, the mechanisms mediating visual discomfort or
pain are poorly understood. Research in the early 1900s demonstrated that several
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functioning anatomical structures were necessary to experience PP. Although the retina
is insensible to pain, it seems logical that the photoreceptors play a role in PP. Siegwart
(1920) showed that only wavelengths of light within the visible spectrum could produce
PP. Further, he showed that individuals with bilateral blindness could not experience
visual discomfort in response to light. In three individuals with unilateral blindness, iris
constriction and pain was reported in the blind eye when the functioning eye was exposed
to light (Siegwart, 1920). Other investigators also demonstrated that iris constriction was
involved in PP. For example, in one study, pharmacological dilation of subjects’ pupils
alleviated the visual discomfort they previously experienced when entering sunlight
(Nagel, 1901). These findings suggest the neural pathway responsible for (bilateral) iris
constriction may be necessary to experience visual discomfort; in particular, the optic
tract projecting to the Edinger-Westphal nuclei in the pretectal midbrain, and the inferior
division o f the oculomotor nerve (3rd cranial nerve), which connects these nuclei with the
iris sphincter. After noting that the iris dilates and constricts with some rate of recurrence
when the eye is exposed to bright light (i.e., hippus), Hopkinson (1956) suggested that
oscillations o f the iris might be involved in visual discomfort. Although research by
Howarth and colleagues (1972) failed to corroborate this possibility, an intact trigeminal
nerve (5th cranial nerve), connecting to the ciliary body and the iris dilator muscle via the
nasociliary and long ciliary nerves, is necessary to experience PP (Lebenson, 1951).
Recently, Stringham et al. (manuscript submitted for publication) conducted a series of
experiments revealing that small bistratified and parasol ganglion cells may mediate PP.
Small bistratified ganglion cells are thought to contribute to the blue-yellow opponent
processes, and give rise to the koniocellular pathway (Kremers et al., 2001). Parasol cells
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give rise to the magnocellular visual pathway, which is involved in processing depth,
movement and is characterized by a luminosity function (Kaplan & Shapley, 1986;
Livingstone & Hubei, 1987). Interestingly, some parasol ganglion cells project to
pretectal nuclei (Rodieck, 1998), perhaps contributing to iris constriction.
Few studies have investigated the stimulus parameters mediating PP. Instead,
most research has focused on a similar phenomenon called discomfort glare—a condition
in which distracting, possibly discomforting, light sources are located in the peripheral
field of view (Vos, 2003). Most research investigating the stimulus parameters necessary
to elicit discomfort glare (or PP) in normal observers has relied on subject self-report.
Typically, subjects are asked to rate their visual discomfort in response to a stimulus
using the standardized de Boer scale (de Boer, 1967), which ranges from 1 (unbearable)
to 9 (just noticeable). Using this scale, Sivak et al. (1999) found that both the intensity
and duration o f a light source significantly affected observers’ ratings of discomfort. As
the duration or intensity o f the light source increased, so did the apparent level of visual
discomfort. Other investigators have reported that discomfort thresholds are lower for
binocular targets (Vanagaite et al., 1997; Vanagaite-Vingen & Stovner, 1998), suggesting
that visual discomfort may involve binocular summation. Waters et al. (1995)
demonstrated that nonuniform stimuli (i.e., gratings) presented in the peripheral retina
were less discomforting than nonuniform stimuli viewed centrally.
In 1994, Berman et al. introduced the use of electromyography for assessing
discomfort glare. They placed electrodes around the eye and measured muscle
contraction in response to light exposure. This “objective” measure of visual discomfort
is based on the premise that a discomforting light will trigger a contraction of the
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orbicularis muscle, resulting in a reduction of the palpebral fissure (i.e., a squint). For a
glare source located at 11 degrees retinal eccentricity, they found that muscle contraction
increased as the luminance of the light source increased. Further, their subjects appeared
to experience more discomfort when viewing a 2-degree glare source, compared to a 1degree source. In a subsequent study, Berman and colleagues (1996) used this same
objective technique to measure the effects of a light’s spectral emmitance on discomfort.
They found that a light source with more energy in the LW end of the spectrum induced
greater muscle contraction (i.e., discomfort) compared to a light source with more energy
at shorter wavebands. A greater discomfort in response to LW light was also noted by
Main et al. (2000). According to their research, the discomfort thresholds for both LW
and SW light targets are lower than for MW and broad-band targets. Similarly, Kuller
and Wetterberg’s (1993) subjects reported that full-spectrum fluorescent lights
(correlated color temperature > 5000 K) were more discomforting than warm-white
fluorescent lights (correlated color temperature = 3000 K). In a recent, more
experimentally rigorous investigation, Stringham et al. (2003) looked at the effects of
individual wavelengths on the threshold for PP. Unlike other researchers, they controlled
retinal illuminace (pupil size) by using Maxwellian view optics. Their procedure
involved focusing monochromatic targets, subtending 5 degrees o f arc and presented for
5 seconds, on the fovea o f three normal observers. The method of limits was used to
determine the energy necessary to elicit a criterion squinting response as measured by
electromyography at wavelengths between 440nm and 640nm. The normalized action
spectra of PP for all three of the observers showed a high degree of between- and withinsubject uniformity. Figure 2 shows the normalized action spectra for two subjects. As
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(1976; see figure 3). These findings suggest that MP may attenuate PP or discomfort
associated with sufficiently intense SW targets and may impact the threshold for PP
under normal viewing conditions.
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CHAPTER V

RESEARCH OBJECTIVES

The objective o f the present project was to test directly the relationship between
MP and PP. First, it is hypothesized that these two phenomena are positively correlated
such that individuals with higher MPOD will require more energy to experience PP when
viewing a SW target relative to a LW target. Second, in an attempt to establish a causal
relationship, it is hypothesized that augmenting MPOD via lutein supplementation will
result in corresponding increases in the threshold for PP for a SW target relative to a LW
target. If this is the case, increasing MPOD, either through diet or supplementation, may
represent a viable treatment for some individuals who suffer from frequent episodes of
PP.
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CHAPTER VI

METHODS

Measurement o f Macular Pigment Optical Density
The recent interest in MP’s role in the development of AMD has prompted many
researchers to devise methods for measuring retinal lutein and zeaxanthin concentrations
in vivo. These techniques take advantage of the absorption spectrum and retinal
concentration gradient o f MP; specifically, the filtration of SW light by the MP in the
fovea relative to the parafovea. For example, in fundus photographic techniques (e.g.,
Kilbride et al., 1989; Abadi and Cox, 1992), two images of a bleached retina are
obtained, one using light absorbed by MP and another using light not absorbed by MP.
In the former photograph, the MP will appear dark to black. The two photographs are
digitized, rendered in grayscale, then aligned using ocular landmarks. MPOD is obtained
by subtracting the density differences (grayness) at each pixel between the two
photographs. In another technique, a reflection spectrum of the retina is obtained using a
scanning laser ophthalmoscope (e.g., Berendschot et al., 2000; Wiistemeyer et al., 2003).
This instrument measures the amount of monochromatic light reflected from various
retinal loci. To calculate MPOD, the amount of (reflected) energy recorded by a
photodetector when the laser falls outside the fovea is compared to the energy when the
laser falls on loci in the fovea. Two additional techniques also measure MPOD using
reflectometric methods. Bernstein et al. (2002) and Gellerman et al. (2002) measured
MPOD by exposing the fovea and parafovea to an argon laser and measuring the distinct
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Raman signals o f lutein and zeaxanthin. Another innovative technique involves
measuring the amount of lipofuscin fluorescence in the fovea and parafovea after
exposure to SW and MW monochromatic light (e.g., Delori et al., 2G01). Unfortunately,
all of the aforementioned techniques require pupillary dilation with mydriatics, and
consequently, a lengthy time investment from the subject.
One of the quicker and easier techniques to measure MP, and hence the most
popular, involves measuring the effects of MP on spectral sensitivity using a
psychophysical technique called heterochromatic flicker photometry (HFP). Like other
in vivo measures, this technique takes advantage of the absorption spectrum and retinal
concentration gradient of MP; specifically, the filtration of SW light by the MP in the
fovea relative to the parafovea. Because the MP absorbs some SW light before it reaches
the photopigments, an estimate of MPOD can be obtained by comparing the spectral
sensitivity o f retinal loci screened by MP with loci where lutein and zeaxanthin do not
accumulate. This possibility, however, is predicated on these two retinal loci having
identical spectral sensitivities, save the intervention of MP.
The concentration o f MP declines exponentially with increasing eccentricity, such
that less than 5 percent of the total lutein and zeaxanthin in the retina accumulates beyond
1.6mm (« 5 degrees). Consequently, retinal loci five degrees outside the foveal center
can be used to obtain a spectral sensitivity relatively unaffected by MP. To compare
spectral sensitivities between the foveola and say, a locus 7 degrees outside the fovea, the
testing conditions must favor the input o f MW and LW cones while eliminating or
diminishing the input of SW cones and rods. These actions are necessary because only
MW and LW cones remain in relatively equal proportion to one another from the foveola
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to 7 degrees eccentricity (Cicerone & Nerger, 1989; Nerger & Cicerone, 1992). The
distribution o f rods and SW cones, on the other hand, changes dramatically across the
macula (0sterberg, 1935; Curcio et al., 1991). One way to diminish the involvement of
rods and SW cones in spectral sensitivity measures is to conduct the test using
background light that is more strongly absorbed by these receptor types than by MW and
LW cones. A background composed of SW light renders the SW cones and rods
insensitive to the lights used to measure MPOD. The importance o f conducting the test
on a SW background is illustrated in figure 4. As one can see, measures of MPOD are
relatively unaffected by a broad range of background intensities provided they exceed
about 2 log Td, but a barely perceptible background, or no background, results in
profound overestimations of MPOD
owing to the intrusion of SW cones
and rods. Additionally, using a
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Figure 4: Mean macular pigment optical density
(MPOD) as a function o f background intensity. The
function represents a mean o f six sessions for one
subject (AW). MPOD was measured in free view at
30' eccentricity using the Macular Metrics optical
system. The flicker frequency o f the target was not
adjusted during an experimental session.

flickering disc superimposed on a
large, SW background. The flickering
disc is composed o f two
monochromatic lights that alternate in
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square-wave counter phase between a reference light and a test light (see figure 5). The
radiance and wavelength
composition o f the reference
Fixation Point

6 degree, 470nm

light remain invariant, while

Background

the test light’s radiance and
1 degree, 460 / 570nn
Test Stimulus

wavelength composition are
manipulated. To measure
MPOD, it is necessary to
use a reference light

Square-wave counterphase presentation o f test stimulus

composed of a wavelength
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outside the absorption
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Figure 5: Schematic o f the stimulus used to measure macular
pigment optical density with heterochromatic flicker photometry.
Below the schematic is a graphical representation o f the counter
phase presentation o f the test stimulus.

chromatic composition of
the test light is varied,
allowing MPOD estimates

at different wavelengths. For each test wavelength, the subject adjusts the radiance of the
test light until the test stimulus appears to stop flickering—a condition referred to as
sensation luminance (Kaiser, 1988). Measuring the energy necessary for a subject to
achieve sensation luminance at various wavelengths yields a spectral sensitivity curve.
By obtaining two such spectral sensitivity curves, one in the fovea and another in the
parafovea, researchers can determine the effect of MP on spectral sensitivity by
normalizing the two functions (see figure 6). A measurement of MPOD can be
calculated by taking the log ratio of these two functions. That is, for each test
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Figure 6: Foveal and parafoveal spectral sensitivity
functions measured using heterochromatic flicker
photometry. The data are normalized at 560nm.
The log ratio o f the two functions is attributable to
absorption by macular pigment.

spectrophotometry (Bone et al.,
1985), microdensitometry
(Snodderly et al., 1984), and fundus
reflectometry (Kilbride et al.,

1989). To obtain a MP absorption spectrum with HFP requires a lengthy time investment
from the subject. As a result, most researchers simply measure MPOD at 460nm, as this
is the wavelength of peak absorption. Cautious researchers also occasionally measure
MPOD at 490nm as a validity check for a subject’s 460nm measure. Measurements
using a 490nm test light should yield MPOD approximately half the value obtained using
a 460nm test light (Wyszecki & Stiles, 1982).
In 1987, Wemer et al. measured MPOD after manipulating several parameters of
the HFP task. O f particular interest was their finding that MPOD was predicated on the
radius o f the foveal test stimulus, or more appropriately, its visual angle. They found that
as the visual angle of a centrally fixated test stimulus increased, MPOD decreased
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exponentially. The relationship between the radius of the test stimulus and MPOD
corresponded well with the retinal concentration gradient of MP established with HPLC.
This finding suggests that MPOD is predicated on the effects of MP absorption at the
edge of a flickering test stimulus. For example, the edge of a centrally fixated one-degree
test disc will extend to 0.5 degrees eccentricity, and will yield a measure of sensation
luminance affected by MP absorption at this retinal locus. The fact that sensation
luminance is dependent on MP absorption at the edge of a flickering disc target, and not
on space-averaged MPOD, is further supported by the observation that a one-degree
annulus yields the same
measure of sensation
luminance as a one-degree test
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Figure 7: Schematic o f the retinal loci and corresponding
macular pigment optical density profile assessed using the
Macular Metrics densitometer. Stimuli A and B are centrally
fixated discs that subtend 40' and 60' o f visual angle,
respectively. Stimuli C and D are centrally fixated annuli,
with outer edges subtending 120' and 240', respectively. The
widths o f the annuli subtend 20' o f visual angle. Stimulus E is
a 120' disc centered at seven degrees eccentricity by the
subject's fixating a small point o f light to the left o f the
stimulus.
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between 20-minutes and 2-degrees eccentricity (see figure 7). The test stimuli were
presented in free-view using an optical system recently developed by the Macular Metrics
Corporation ® (Rehoboth, MA; see Wooten et al., 1999). This system produces the test
stimuli with an arrangement of 4 LEDS—two with a peak wavelength at 458nm, one
with a peak at 490nm, and the fourth with a peak at 530nm. The 530nm LED (1.7 log
Td) is electronically driven to alternate in square-wave with either the two 458nm LEDs,
for estimates o f MPOD at its wavelength of peak absorption, or the one 490nm LED for
density estimates at this test wavelength. Light from these LEDs is collimated by a
planoconvex lens and defined by one of five apertures constructed o f Mylar film.
Another LED arrangement, comprised of 4 LEDS with a peak spectral emmitance at
470nm is used to produce the background (1.5 log Td). Light from this arrangement
passes through a planoconvex lens and is defined by a 6-degree aperture. Finally, light
from both LED arrangements is combined using a beam-splitter. When the subject’s
right eye is properly aligned with the optical axis of the beam splitter, the stimulus
appears as a flickering test disc (or annulus) superimposed on a large, SW background
(figure 5). At the center of the flickering test stimulus is a small, 5-minutes of arc,
fixation point. For the four foveal measures of sensation luminance, the subject fixates
this small point as he or she adjusts the intensity of the test LED(s) until flicker is
minimized or eliminated. To perform the reference parafoveal measure, the subject
fixates a small, LW LED approximately 7 degrees of visual angle from the center o f a
two-degree test stimulus (disc). This fixation point is located to the left of the test image,
resulting in a nasal reference measure of sensation luminance. The subject’s task,
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however, is identical to the foveal task: to adjust the energy of the test LED(s) until the
test stimulus appears stable (i.e., stops flickering).
The ability to stabilize the flickering test stimulus is highly dependent on the
flicker frequency of the target, especially in the fovea. If the flicker frequency is too low,
the subject will likely be unable to eliminate the apparent flicker o f the test target. On the
other hand, if the flicker frequency is too high, the test stimulus will appear stable for a
broad range o f energy (i.e., radiance) supplied to the LED(s). Ideally, the subject should
be able to adjust the intensity of the test LED(s) to observe a “zone” of flicker on both
sides o f a small null zone—range of radiances for which the test stimulus appears not to
flicker. The subject’s specific task
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Figure 8: Relationship between flicker frequency o f the
test stimulus and size o f the null zone in HFP for one
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zone and flicker frequency are
related positively, such that
increasing the flicker frequency
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tends to increase the null zone. The relationship between flicker frequency and null zone
size is illustrated in figure 8. In the current project, the flicker frequency of each target
was adjusted until the subject perceived a null zone that spanned approximately 100
radiance units according to the Macular Metrics’ photometer readout. A null zone of this
size is small enough to limit subject variability, but large enough so that subjects can
easily and consistently perform estimations of the null zone’s mid point. Regardless of
the size o f the null zone, subjects rarely select the exact same mid-point on successive
attempts. In order to reduce the effects of such variability, multiple measures are
obtained. In fact, data reported by Werner et al. (1987) suggest that the flicker frequency
of the target has little effect on calculations of MPOD when several mid-point
estimations are obtained for each target. Eight mid-point estimations were obtained for
each test stimulus in the current project. The mean radiance of these eight measures was
used to calculate MPOD at each eccentricity.
Measurement o f Photophobia
Previous researchers investigating the stimulus conditions necessary to induce
visual discomfort have failed to control the amount of light entering the eye. Only
Stringham et al. (2003) controlled retinal illuminance by presenting their stimuli in
Maxwellian view. In this technique, light is focused at the plane of the pupil to a beam
narrower than the smallest aperture achievable by the iris, thereby obviating the effects of
pupil size on retinal illuminance. This same technique was used in the current
experiment. In short, a three-channel Maxwellian view optical system was used to
produce the PP test stimuli. One channel was used to produce an 8.2-degree, broadband
test stimulus. Light in this channel passed through either a SW broadband filter (Oriel
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photophobia thresholds. The light passing through
the “blue” broadband filter falls within the
absorption spectrum o f macular pigment (MP). In
contrast, the MP does not absorb any apppreciable
wavelengths o f light passing through the “orange”
broadband filter.

spectrum o f MP. Another channel
was used to create a mesopic (-1
log cd/m ), broadband, 30.5-degree
background. The third channel

produced a small, 20 minutes of arc, LW fixation light. A schematic of the PP test
stimulus is depicted in figure 10. Neutral density filters were used to control the energy
in each channel.
At the beginning of each experimental session, the subject’s right pupil was
aligned with the optical axis of the system using a reticle. Throughout the experiment a
dental impression and forehead rests were used by the subject to maintain this position.
After the alignment procedure, subjects dark adapted for 20 minutes. Subjects then
fixated the small LW light for two minutes. This fixation light was located either
centrally, for foveal measures of PP, or at 10.1 degrees temporal eccentricity for
parafoveal measures of PP. After the subject adapted to the background for two minutes,
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the experimenter announced that the PP stimulus was to be presented. The time between
the experimenter’s cue and the presentation of the test target was quasi-random, between
5 and 20 seconds. After
the five-second

Fovea Stimulus

presentation of the test
30.5 degree

background

target, subjects rated
.2 degree disc

their level of visual
discomfort using a 10point psychophysical
Parafovea Stimulus

scale, where a 1
30.5 degree

background

represented no
discomfort and a 10

•.2 degree disc

represented PP—i.e., the
20 minute fixation point at
10.1 degrees o f eccentricity

light caused sufficient
discomfort to elicit a

Figure 10: Schematic o f the foveal and parafoveal test stimuli used
to measure photophobia thresholds. For each retinal loci, the 8.2
degree test disk was composed o f light passing through either the
broadband “blue” filter or the broadband “orange” filter (see text).

squint and subjects
wanted to divert their

eye from the target. The initial test target was well below the subject’s PP threshold. By
use of the method of ascending limits, the energy of the test light was increased by
subtracting neutral density from channel one. If the subjects rated their discomfort
between 5 and 9, 0.1 log units of density was subtracted, otherwise 0.3 log units was
removed from the channel. Random catch trials were performed to assess subject bias.
After each presentation o f the test stimulus, the experimenter rolled two die. If the sum
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o f the die was 2, 0.1 log units of density was added to the test channel. If the subject
correctly rated the stimulus as less intense (i.e., a lower number) than the previous target,
the response was recorded as a “hit.” Conversely, if the subject incorrectly rated the
stimulus, rating it as equally or more discomforting than the previous stimulus, it was
recorded as a “false alarm” (FA). Additional non-random catch trials were also
performed by the experimenter to better define subjects’ PP thresholds. To maintain the
same level o f retinal sensitivity prior to each presentation of the test stimulus, subjects
covered their right eye with an eyepatch and dark adapted for fifteen minutes between
trials. This procedure was repeated until the subject reported that he or she experienced
PP (i.e., a rating of 10) while viewing the test stimulus. PP thresholds for the 8.2 degree
test stimulus were measured for the SW (“blue”) target in the fovea and parafovea and for
the MW- to LW (“orange”) target in the fovea and parafovea. The four test conditions
are illustrated in figure 11. After the experiment, the energy of the test lights which
induced PP were measured using a radiometer (United Detector Technology Optomteter
#61). The energy of the four targets was log transformed, and 0.46 log units was
subtracted from the log orange energy to correct for the orange filter’s greater energy
transmission. The corrected log energy of the orange target that induced PP was then
subtracted from the log energy of the blue target that induced PP to yield a foveal PP
ratio. A parafoveal PP ratio was calculated in the same manner. Finally, a difference
ratio (PP ratio) was calculated by subtracting the parafoveal PP ratio from the foveal PP
ratio. Before the project was initiated, the above procedure was used to compare PP
thresholds measured with a scaling technique to those determined with electromyography
(electromyogram—EMG). Most of the studies investigating visual discomfort asked
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Fovea

Parafovea
Log Energy for
Photophobia =

Log Energy for
Photophobia =

2.289

3.107

D
Log Energy for
Photophobia =

Log Energy for
Photophobia =

2.441

2.501

Fovea Photophobia Ratio = 0.152

Parafovea Photophobia Ratio = -0.606
Difference Ratio (PP Ratio) = 0.758

Figure 11: Schematic o f the four photophobia (PP) test stimuli used to measure PP thresholds.
Stimuli A and B were used to measure foveal PP thresholds for the “orange” and “blue” lights,
respectively. Stimuli C and D were used to measure parafoveal PP thresholds for the orange and
blue lights, respectively. The calculation o f PP ratio is illustrated with an example. In the fovea
and parafovea, the log relative energy necessary to induce PP for the orange stimulus was
subtracted from the energy necessary to induce PP with the blue stimulus. The absolute difference
between these two ratios was called the PP ratio.

subjects to use a scale (as was the case in the present study), such as the de Boer scale (de
Boer, 1967), to quantify their level of discomfort when viewing a light source. As
mentioned earlier, two groups of researchers, however, attempted to measure PP using an
“objective” procedure. Both Berman et al. (1994) and Stringham et al. (2003) recorded
gross muscle potentials around the eye (EMG) while their subjects viewed a light source.
Essentially, these researchers assumed that a sufficiently bright light will compel a
subject to squint in order to limit the amount of light entering the eye. When the signalto-noise ratio of the EMG trace (i.e., squint magnitude) exceeded a criterion value, the
subject was defined operationally to have experienced PP. Berman et al. (1994) and
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Stringham et al. (2003) also asked their subjects to rate their level of discomfort using a
scale. Interestingly, both groups of researchers noted a high degree o f correspondence
between squint magnitude and the subjects’ subjective rating of discomfort. In fact,
Stringham et al. showed that the PP action spectrum obtained using EMG looked
essentially identical to the spectrum based on their subjects’ subjective ratings of lights
just below the PP threshold. Their subjects used the samelO-point psychophysical scale
used in the present study, where 1 signified no discomfort and a 10 represented PP.
Figure 12 shows their subjects’
Ratings of 9 spectra
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action spectra for subjective ratings
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0.0 0 -

EMG PP Spectra
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discomfort, bordering on PP,

>
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of “9,” which represent extreme
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spectra of PP. The similarity
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between the scaling and EMG
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functions suggests that a rating scale
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Wavelength (nm)

is a viable option for estimating PP,
particularly if subjects are well

Figure 12: Mean electromyographic and scaling
photophobia action spectra for two subjects in
Stringham et al’s (2003) study. The functions are
normalized at 500nm.

trained and PP is well defined.
In the studies by Berman et

al. and Stringham et al., the high degree of correspondence between the objective (EMG)
and subjective (scale) values may have been partly due to the fact that the scaling
procedures were coincident with the EMG recordings. To obviate this possibility, one
naive subject and one well trained subject had their PP thresholds for the blue and orange
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targets measured in two separate sessions. In one session, PP thresholds were measured
using the aforementioned techniques (i.e., subjects used a psychophysical scale). In the
other session, PP thresholds for the same four targets were determined using EMG.
Three nickel-plated, surface electrodes were used to record gross potentials generated
during a squint: one electrode was attached below the subject’s right eye (test), another
on the subject’s right temple (reference), and a third on the back of the subject’s neck
(ground). The electrodes were connected to a Grass Instruments amplifier (#7P3B),
which sent the signal to a waveform computer program. As in Stringham et al., PP was
defined as a signal-to-noise ratio of 4:1 on the EMG trace lasting at least 2.5 seconds.
The data for both subjects’ sessions are presented in figure 13. The high degree of
similarity between the two
sessions, particularly JMS’s
Subject MW:
— EMG
• Scaling
Subject JS:
—o— EMG
—o —Scaling

02
<
oCD
> “
-

-

functions, suggests that a scaling
technique can be reliably used to

TO
O
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S
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oo>
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determine PP thresholds. Further, a
psychophysical scaling procedure
has two primary advantages over
EMG for determining PP

a:

O)
o -o.e

thresholds. It is less invasive for
Fovea

Parafovea

the subject; and more importantly,
Figure 13: Foveal and parafoveal photophobia ratios
for two subjects measured with electromyography
and a scaling technique. The data are not
normalized.

EMG can only be used to measure
squint magnitude (behavior), not
visual discomfort (PP).
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Experimental Protocol
To adequately investigate the impact of MPOD on PP, two separate experiments
were performed. The primary goal of the first experiment was to investigate the
correlation between MPOD and the energy necessary to induce PP for the blue target
relative to the orange target. Using the aforementioned techniques, MPOD and PP
thresholds were measured in ten, non-smoking individuals, four males and six females,
ages 21 to 33.
The primary goal o f the second experiment was to measure the effects of
augmented MPOD on the energy needed to induce PP for the four targets. Four subjects
from experiment one, two males and two females, ages 24 to 31, took 60mg of
Xangold™ (Cognis, La Grange, IL) dietary supplements daily for twelve weeks. The
dosage was equal to approximately 30mg of free lutein per day. During the twelve weeks
o f intervention, subjects continued their regular diet. PP thresholds and MPOD were
measured at baseline and again after six weeks and twelve weeks of supplementation.
The use o f human subjects in this project was approved by the University of New
Hampshire Institutional Review Board.
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CHAPTER VII

RESULTS1

Experiment One
The sample’s mean age, BMI, and MPOD at each eccentricity are presented in
table 1 (see Apendix A). BMI was linearly correlated with MPOD at 60' eccentricity (r =
0.786, n = 10, p = 0.006), although this relationship was largely driven by two outliers.
Age, on the other hand, was not significantly correlated with MPOD at any eccentricity.
The mean MPOD profiles for
males and females are illustrated

0.55

-males
- females

0.50-

in figure 14. Although the

0.45

sample mean male MPOD profile

0.40
0.35-

is higher at the three central loci,

0.30
0.25-

and the female sample mean at

0.20

0.15

120' eccentricity, the differences

0.10

0.05

were not statistically significant

0.00

—r~
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according to independent sample

Nasal Retinal Eccentricity (minutes)

t-tests. Likewise, there was no
Figure 14: Mean male (n = 4) and female (n = 6)
macular pigment optical density (MPOD) profiles.
A-A + ■ -r A A-ee u ,
i
j
MPOD did not significantly differ between males and
females at any loci.

significance difference in BMI or
age between males and females.

1 The familywise error rate (i.e., probability o f making one or more type I errors) for all planned contrasts is
0.641.
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The ten subjects’ MPOD
at each eccentricity and PP ratios
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were plotted and fit with a linear
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In the event that PP
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total screening was calculated by
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Figure 15: Relationship between PP ratio and
MPOD. There was a significantly linear
relationship between PP ratio and MPOD at 20' (A,
p = 0.009), 30' (B, p = 0.010), and 60' (C, p =
0.025) eccentricity. MPOD at 120' (D, p = 0.750)
eccentricity was not linearly related to PP ratio.

profile. Each subject’s MPOD
profile was plotted and fit with a
Gaussian function, using Origin
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7.0® (Northampton, MA). The area under the MPOD profile was calculated to yield a
Gaussian integrated MPOD (iGMPOD). Several previous researchers have used the
Gaussian function to explain the foveal distribution of MP (e.g., Snodderly et al., 2004).
The Gassian function can be
0.9

described with the following
0 .8 -

formula:
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asymptote); A = total area under the
curve from the baseline; Xo =center
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of the peak (i.e., mean); w = width
of the peak at half height. Figure

0.50.4-

16a shows subject AW ’s MPOD
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profile fit with a Gaussian function.
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The Gaussian function appears to
0.0

-

-400

-300

-200

-100

0

100

200

300

describe the MPOD profile well,
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Retinal Eccentricity (minutes)
tem poral - nasal

with an R2 = 0.994. For the other

Figure 16: Subject AW ’s macular pigment optical
density profiles fit with a Gaussian function (A) and a
Lorentzian function (B).

nine subjects, the R2 for the
Gaussian fit ranged from 0.999 to
0.817. The iGMPOD and PP ratios
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for each subject are plotted in figure 17a. As one can see, there was a strong positive
relationship between iGMPOD and PP ratio (r = 0.830, n = 10, p = 0.002).
The fovea distribution of
MP has also been estimated using
the Lorentzian distribution (e.g.,
Stringham et al., 2003). The

Q

O 40-

Lorentzian distribution can be
described by the following
formula:
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subject AW’s MPOD profile fit
with a Lorentzian function. For
subject AW, the Lorentzian
distribution appears to “fit” his
MPOD profile slightly better than

Figure 17: Relationship between integrated
macular pigment optical density (iMPOD) and
photophobia ratio (PP ratio). The top panel (A)
shows the significant, positive relationship
between integrated Gaussian MPOD and PP ratio
(p = 0.002). The bottom panel (B) shows the
significant linear relationship between integrated
Lorentzian MPOD and PP ratio (p = 0.008).

the Gaussian distribution, with an R2 of 0.999. Except for two subjects, the Lorentzian
distribution fit each subject’s MPOD profile slightly better (i.e., higher R2) than did the
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Gaussian function. For one subject, the Gaussian distribution fit his MPOD profile
better, and for another subject, who had virtually no MP, the Gaussian distribution and
Lorentzian distribution had the same coefficient o f determination (R2 = 0.810). The area
under the Lorentzian fit of each subject’s MPOD profile was calculated to estimate an
integrated Lorentzian MPOD (iLMPOD). The relationship between iLMPOD and PP
ratio is shown in figure 17b. Like iGMPOD, iLMPOD was positively related to PP ratio
(r = 0.775, n = 10, p = 0.008).
To properly fit each subject’s MPOD profile with the Gaussian and Lorentzian
functions, it was necessary to estimate their temporal MPOD profile. Previous research
has demonstrated that MP is distributed symmetrically about the fovea (Hammond et al.,
1997b), such that MPOD at 30' eccentricity in the nasal retina is nearly identical to
MPOD at 30' in the temporal retina. Consequently, an estimate of MPOD in the temporal
retina may be obtained by taking the MPOD measured at a corresponding locus in the
nasal retina. This possibility was tested by measuring a detailed nasal and temporal
MPOD profile in two subjects. The profiles were measured using the Macular Metrics
optical system mentioned above, with one modification: additional fixation points were
added to measure sensation luminance at 150' and 300' eccentricity in the nasal and
temporal retina, and seven-degrees in the temporal retina. As shown in figure 18a-b,
there was a high degree o f uniformity between the subjects’ nasal and temporal MPOD
profiles. In fact, for subject JMS, the two profiles match almost perfectly. The iGMPOD
using both profiles is 41.63 for JMS and 69.89 for AW. When iGMPOD is calculated
using the nasal profile and an estimated temporal profile (as was done in the calculations
above), iGMPOD for JMS is 41.75, and for AW, 67.33. The iLMPOD for JMS, using
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both the nasal and temporal profiles, was 60.27, and for subject AW, 103.28. Calculating
iLMPOD using the nasal profile and an estimated temporal profile yielded an integrated
area of 60.54 for JMS, and 99.43 for
AW. Thus, using the nasal profile to
0.40-j

estimate MPOD in the temporal
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Figure 18: Nasal and temporal macular pigment
optical density (MPOD) profiles for subjects JMS
(A) and AW (B). The profiles are normalized at
420' eccentricity.

the nasal retina and using these
values as a measure of MPOD in the
temporal retina.
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Experiment Two
The four subjects’ MPOD profiles at baseline and after six and twelve weeks of
lutein intervention are depicted in figure 19a-d. The group’s mean MPOD profile at
baseline, visit two and visit three is shown in figure 20. The figure shows that mean
MPOD increased slightly at the central three loci after six weeks of intervention by the
consumption o f approximately l,260mg of lutein (30mg per day). After an additional six
weeks o f lutein intervention, mean MPOD increased another 0.04 log units at the two
central loci and about 0.02 log units at the other two loci. According to a randomized
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Figure 19: Macular pigment optical density profiles for the four subjects in Experiment
Two at baseline and after six-weeks (visit 2) and twelve-weeks (visit 3) o f lutein
intervention. The MPOD profiles are normalized at 420' eccentricity. Panels A, B, C,
and D show the MPOD profiles for subjects JPS, LS, AW and MW, respectively.
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block design (RB-3; Kirk, 1995;
pages 251-286), MPOD
0 .5-

significantly increased from
baseline at 20' (F2,6 = 17.35, p =
<0 0.3-
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these three loci after six and
Figure 20: Mean macular pigment optical density
profiles for the subjects in Experiment Two at baseline
and after six-weeks (visit 2) and twelve-weeks (visit 3)
o f lutein intervention. According to a subjects-by-trials
analysis, MPOD significantly increased from baseline at
20' (p = 0.003), 30' (p < 0.001), and 60' (p = 0.026)
eccentricity.

twelve weeks of lutein
intervention can be described by a
linear trend (20': F = 26.04, p =
0.014, co2 = 0.89; 30': F = 495.70,

p < 0.001, 0 )z = 0.93; 60': F = 11.29, p = 0.043, a/' = 0.74), according to analyses using
orthogonal polynomial contrasts. Changes in MPOD did not depart from linearity.
An integrated MPOD was calculated for each subject’s three MPOD profiles
using the aforementioned Gaussian and Lorentzian distributions. The Lorentzian
distribution fit the data slightly better than did the Gaussian function for three of the four
2

2

subjects, using R as a measure of “goodness of fit.” For the Gaussian f it, R ranged
from 0.999 to 0.950, and for the Lorentzian fit, it ranged from 0.999 to 0.984. Mean
iGMPOD increased from 50.86 (SD = 18.30) at baseline to 56.10 (SD = 17.88) after six
weeks o f intervention, and to 60.27 (SD = 19.48) after twelve weeks. Mean iLMPOD
increased from 74.69 (SD = 26.78) at baseline to 84.27 (SD = 25.55) after six weeks of
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intervention, and to 92.63 (SD = 29.41) after twelve weeks. Thus, after six weeks of
intervention, the area under the mean MPOD profiles increased approximately 11
percent, and after twelve weeks, approximately 22 percent. Both iGMPOD (F2,6 = 9.12, p
= 0.015, co2 = 0.57) and iLMPOD (F2,6 = 17.35, p 0.003, co2 = 0.73) significantly changed
from baseline, according to analyses using an RB-3 design. A linear trend described the
changes in iGMPOD (F = 16.74, p = 0.026, ©2 = 0.75) and iLMPOD (F = 39.75, p =
0.008, co2 = 0.83), with no
departures from linearity.

IZZ2Visit2
Visrt3

The PP ratios for each

0 8 .

subject increased after six weeks
of intervention, and in three

ca 0.5
Q_ 0 .4 -

subjects, increased from visit two
to visit three (see figure 21). A
subjects-by-trial (RB-3) design
revealed that PP ratios
Figure

21: Photophobia ratios (PP „ tio )

for the four

subjects in Experiment Two at baseline and after sixweeks (visit 2) and twelve-weeks (visit 3) o f lutein
intervention. The subjects’ mean PP ratio
significantly increased from baseline (p = 0.011)
according to a subjects-by-trials design.

significantly changed after twelve
weeks of lutein intervention

(F 2i6

= 10.41, p = 0.011, co =0.61).
As was the case for MPOD, a

linear trend appeared to describe the changes in PP ratio (F = 13.09, p = 0.036, co2 =
0 . 86).

Figure 22a-b shows the ten PP ratios and corresponding iGMPOD (a) and
iLMPOD (b) from Experiment One, as well as the additional eight data points from
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Lorentzian Integrated MPOD
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Figure 22: The combined Gaussian (A) and
Lorentzian (B) integrated macular pigment optical
densities (MPOD) and photophobia ratios (PP ratio)
observed in Experiment One and Experiment Two.
Two linear fits are plotted in each panel. One linear
fit shows the relationship observed in Experiment
One (solid line), whereas the second shows the
relationship between integrated MPOD and PP ratio
for the combined data o f both experiments (dotted
line). The repeat measures for the four subjects in
Experiment Two are connected with solid lines.

trials were performed while
measuring PP ratios in both
Experiments. An additional
seventeen non-random catch trials
were used by the Experimenter to
better define subjects’ PP
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thresholds. The random catch
trials had a hit:FA ratio of 12:1
0.75-

and the non-random catch trials
had a hit:FA ratio o f 7.5:1. Catch
trials were not used in previous
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Lorentzian Integrated MPOD

Figure 23: Linear relationships between photophobia
ratio and integrated Gaussian (A) and Lorentzian (B)
macular pigment optical density after removing
subject CF’s data. Both panels contain linear fits o f
the data from Experiment One (solid line), as well as
a linear fit o f the combined data from both
Experiments (dotted line). The repeat measures for
the four subjects in Experiment Two are connected
with solid lines.
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CHAPTER VIII

DISCUSSION

The main finding of this project was that MPOD was associated with PP
thresholds for a SW target relative to a MW target. In Experiment One, MPOD at three
foveal loci was positively correlated with PP ratios, as was Gaussian and Lorentzian
integrated MPOD. In Experiment Two, significant increases in MPOD after twelve
weeks of lutein supplementation resulted in significant increases in PP ratios.
Distribution o f Macular Pigment
The MPOD of the subjects in Experiment One is similar to previous research
conducted using HFP. In several studies, Hammond et al. (1995; 1996a, b, c; 1997b)
reported that MPOD at 30' eccentricity ranged between 0.10 and 0.57. For the small
sample in Experiment One, MPOD ranged between 0.06 and 0.51 at 30' eccentricity.
One consideration in comparing the results of the current project to those of Hammond
and colleagues involves the spectral bandwidth of the test lights. In the studies by
Hammond et al., the half-bandwidth of the test light was 8nm, whereas the halfbandwidth of the test light in the current project was 20nm. The broader spectral
emission of test light used in the current study will result in a greater underestimation of
MPOD at 460nm than the one used by Hammond and colleagues. Although it is
negligible, another consideration is the peak wavelength of the test lights used by
Hammond et al. In their studies, the peak wavelength o f the test light was 460nm, the
absorption peak of MP, whereas the test light in the Macular Metrics system has a peak
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wavelength o f 458nm, 99.8% o f the MP absorption peak. Regardless of the half
bandwidth or peak wavelength of the test lights, the mean MPOD at 30' eccentricity for
subjects in Experiment One is considerably higher than the mean MPOD reported in
larger studies (n > 200) that used the Macular Metrics optical system. In a Midwest
sample, Cuilla et al. (2001a) found that the mean MPOD at 30' was 0.211 (SD = 0.13).
Similarly, the mean MPOD at 30' eccentricity in Hammond and Caruso-Avery’s
Southwest sample was 0.22 (SD = 0.13). One possible explanation for the difference
between these mean values and the values in this study is the retinal eccentricity of the
parafoveal measure. In the current project, a sensation luminance unaffected by MP
(reference) was obtained at six-degrees eccentricity. Cuilla et al. and Hammond and
Caruso-Avery used a reference point of four-degrees eccentricity. If MP is present at
four-degrees eccentricity, and some research supports this possibility (e.g., Robson et al.,
2003), a reference measure at this locus will be a spurious measure o f sensation
luminance unaffected by MP. In other words, subjects’ MPOD at 30' eccentricity would
be underestimated by their amount of MPOD at four-degrees. The spectral composition
of the test target and eccentricity of the reference measure are just two factors that make
between-study comparisons difficult. The ability to compare results between studies is
further complicated by the manifold techniques used to measure MPOD in vivo.
However, the range and mean MPOD in the current sample agrees well with values
reported using other techniques and optical systems for nearly the same retinal loci (e.g.,
Kilbride et al., 1989; Beatty et al., 2001; Robson et al., 2003).
Few researchers have used HFP to measure MPOD across the fovea. One of the
first was Wemer et al. (1987), who measured MPOD at six retinal loci in one observer to
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show that measures o f MPOD using centrally fixated targets are predicated on absorption
at the edge o f the test target. The majority of studies investigating the foveal distribution
o f MP used reflectometry techniques. A general finding across these studies is a high
degree of similarity between the nasal and temporal MP profiles, as well as the inferior
and superior MP profiles. This relationship, or symmetry, has also been noted in studies
using HFP (Hammond et al., 1997b). The symmetry and distribution of MP across the
fovea is often described using a Gaussian function. For example, Chen et al. (2001)
found that the Gaussian function provided a good fit (mean R2 = 0.946, n = 54) for the
MP profiles they obtained using fundus reflectometry. Hammond et al. (1997b) reported
a mean R2 o f 0.82 (n = 32) for the Gaussian fits of their subjects’ MPOD profiles. One
indirect finding of the current study was that the Lorentzian distribution may provide a
better estimate o f the foveal distribution of MP compared to the commonly used
Gaussian distribution. The mean Gaussian R2 for subjects in Experiment One was 0.957.
For the Lorentzian fit, the mean coefficient of determination was 0.968. If the subject
with extremely low MPOD (and an uncharacteristic profile) is removed, the mean
•
2
Gaussian
R is 0.973, and the mean Lorentzian R 2 is 0.986. In both cases, the mean

Gaussian coefficient of determination is higher than those reported by Chen et al. (2001)
and Hammond et al. (1997b). This finding may be the result of chance or reflect reliable
subject performance in the current study. Regardless, the mean Lorentzian R2 is greater
than the Gaussian coefficient of determination, and the Lorentzian distribution provided a
better fit for eight o f the ten subjects’ MPOD profiles in Experiment One. This suggests
that the Lorentzian distribution may provide a better model of MP across the fovea.

49

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The primary limitation of using HFP to measure MPOD profiles is the inability to
measure MPOD at zero degrees eccentricity. To do so would require infinitesimally
small centrally fixated targets. The smallest targets that can be used, however, that will
allow for reliable results are on the order of 12' o f visual angle. Thus, one benefit of
fitting a MPOD profile with a Gaussian or Lorentzian distribution is the ability to
estimate a peak MPOD. A measure of MPOD close to zero degrees was obtained by
Hammond et al. (1997b). They measured MPOD using a centrally fixated 12' target and
referred to this measure as peak MPOD, although it was technically a measure of MPOD
at 6' eccentricity. They found that MPOD at 6' is approximately 39.6% higher than
MPOD at 30' eccentricity. The authors also commented that a Gaussian fit frequently
underestimated this peak. Chen et al. (2001) made the same observation. The mean
estimated Gaussian peak (6' eccentricity) of subjects in Experiment One was
approximately 27.8% higher than their mean MPOD at 30' eccentricity. Given the
relationship between MPOD at 6' and 30' eccentricity observed by Hammond et al.
(1997b), it appears that the Gaussian fit also underestimated peak MPOD in the current
project. However, the Lorentzian estimated peak of subjects in Experiment One was
34.7% higher than their MPOD at 30' eccentricity. This suggests that in addition to
providing a better fit of the MPOD profile, the Lorentzian distribution may provide a
better estimate of peak MPOD than does the Gaussian function.
Lutein Intervention and Macular Pigment Optical Density2
Since lutein and zeaxanthin were identified as the primary constituents of MP
(Bone et al., 1985), numerous researchers have investigated the effects of lutein

2 Table 2 (Appendix B) summarizes the various interventions studies described in this section.
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intervention on MPOD. For example, Hammond et al. (1997a) measured MPOD at 30'
eccentricity during a fifteen-week intervention in which subjects consumed 60g of
spinach and 150g o f com daily. The daily combined dose of lutein was approximately.
11.2mg, and the combined dose of zeaxanthin was approximately 0.6mg. The
intervention provided about four to ten times as much lutein and zeaxanthin as an average
diet (Brady et al., 1996; Tucker et al., 1999; Rock et al. 2002). After four weeks of
intervention, mean MPOD significantly differed from baseline, increasing from 0.39 to
0.50. In the current project, mean MPOD at 30' after twelve weeks of intervention
increased from 0.34 to 0.42, slightly less than the mean change reported by Hammond et
al. The increase in MPOD observed by Hammond et al. (1997a) appeared to plateau after
four weeks of intervention. In contrast, MPOD in the current project increased linearly
from baseline, such that the mean increase in MPOD after six weeks of intervention
(0.04) was approximately half the increase observed at twelve weeks. Further, all four
subjects consuming lutein appeared to respond to the intervention. Three of the ten
subjects consuming spinach and com in Hammond et al.’s study failed to respond to the
increased consumption of lutein and zeaxanthin.
In one “responder”—an individual who shows increases in MPOD as a result of
increased intake of lutein—Hammond et al. (1997a) measured a detailed MPOD profile
at baseline and again after 12 twelve weeks of dietary modification. Changes in MPOD
were not uniform across the central retina. Instead, MPOD increased more in central loci
than in peripheral loci. In this subject, MPOD increased 0.49 log units at 30' eccentricity,
but only 0.08 log units at 3.5 degrees eccentricity. Although this subject appeared to be
an “over” responder, given that the mean increase in MPOD for their sample was only
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about 0.10 log units at 30' eccentricity, the observed changes in MPOD across the central
retina may represent the pattern in which lutein and zeaxanthin are deposited in the
macula. In fact, the same effect was observed in the current study. Mean increases at 20'
and 30' eccentricity were both approximately 0.08 log units, whereas the mean increases
at 60' and 120' eccentricity were only 0.04 and 0.01 log units, respectively. The mean
increase o f the Gaussian estimated peak after twelve weeks of intervention was 0.08; for
the Lorentzian peak it was 0.09. Interestingly, for all four subjects in the current study,
the coefficient o f determination for both the Gaussian and Lorentzian fits of their MPOD
profiles increased from baseline. Likewise, the post-intervention profile reported by
Hammond et al. was better fit with a Gaussian (0.94 compared to 0.96) or Lorentzian
(0.96 compared to 0.98) function than was the baseline profile. These findings suggest
that MPOD does not increase uniformally across the fovea, but instead may follow a
Gaussian or Lorentzian distribution.
One noteworthy difference between the current project and the study conducted
by Hammond et al. (1997a) is the type of intervention: they used a food source of lutein,
whereas a supplement was used in the current project. Although the changes in MPOD
observed in the current study are similar to those of Hammond et al. (1997a) and other
researchers that used natural sources of lutein (Johnson et al., 2000; Curran-Celentano et
al., 2003), the supplement dosage of lutein required to achieve this effect was much
greater. Few studies investigating the effects of lutein supplementation on MPOD found
a significant effect using doses less than 20mg per day. For example, Lariviere et al.
(2002) and Cardinault et al. (2003) failed to observe a significant change in MPOD after
supplementation of 6mg and 9mg per day, respectively. One consideration, in addition to
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the dose size, was the length of intervention in these studies. Both studies measured
MPOD after 5 weeks o f intervention. It may be that changes in MPOD occur after longer
intervention periods when supplements, as opposed to natural sources, are used at doses
below lOmg per day. Preliminary results from an intervention study in which subjects
consumed 2.4mg o f lutein per day suggest that a small dose may significantly increase
MPOD in about sixty-percent of subjects over a six-month period (Bone et al., 2003). In
contrast, Berendschot et al. (2000) claimed a significant increase in MPOD occurred after
only four weeks of intervention with lOmg of lutein per day. Their results, however,
should be viewed with caution, as the reported significance of the effect is clearly not
supported by the data in their figures. The mean increase in MPOD for their small
sample (n = 8) was approximately 0.01 log units after four weeks. Aleman et al. (2001)
investigated the effects o f a six-month intervention on MPOD in normal and diseased
eyes. Their subjects consumed 20mg of lutein supplements daily for six months and had
their MPOD measured at baseline and again after the intervention period. MPOD was
measured using a Macular Metrics densitometer like the one used in the present study
except their smallest target had a visual angle of 20', as opposed to 40'. In normal
subjects, MPOD significantly increased at 10' eccentricity, but not at the three additional
loci. Conversely, mean MPOD in patients with retinitis pigmentosa and Usher syndrome
significantly increased at all four loci. In both groups, mean MPOD increased 0.07 at 10'
eccentricity, and in the diseased eyes, it increased 0.07, 0.08, and 0.04 at 30', 60' and 120'
eccentricity, respectively. Using the same paradigm, Duncan et al. (2002) reported
similar changes in MPOD at these four loci. The significant changes in MPOD reported
by Aleman et al. (2001) and Duncan et al. (2002) agree well with the significant changes

53

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

observed in the current study. If these researchers obtained more frequent measures of
MPOD, a relationship between supplement dose and intervention length could possibly
be estimated by comparing their data to the current project. It may be that the rate of
increase of MPOD is identical in response to either 20mg or 30mg o f lutein per day. This
possibility is based on the findings of a few studies showing that increases in MPOD
plateau after a certain point (e.g., Hammond et al., 1997a). Thus, the six-month profiles
measured by Aleman et al. (2001) and Duncan et al. (2002) may represent MPOD that
reached a saturation point after only twelve weeks of intervention. Alternatively, a
longer intervention may be necessary to achieve a certain effect when using 20mg,
compared to 30mg. For this possibility to be correct, the effects observed by Aleman et
al. (2001) and Duncan et al. (2002) would have to occur after twelve-weeks of
intervention, assuming the increases in these studies are similar to those in the current
project.
Unfortunately, one cannot assess the interaction o f dose and intervention length
by comparing the data available to date (see Table 2). One study, however, investigated
the effects o f intervention length by obtaining frequent measures o f MPOD during
supplementation. Landrum et al. (1997) measured MPOD at 45' eccentricity several
times per week during supplementation with 30mg of lutein per day. Both subjects in
this study responded to the treatment in a similar fashion. After a “lag” period of about
three weeks, MPOD increased linearly throughout the 140 days of intervention. Their
MPOD continued to increase for approximately thirty days after discontinuation of the
supplement and remained at this elevated level for 200 days. The dosage used in the
current project was selected based on the results of Landrum et al. (1997). In particular,
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their subjects’ MPOD increased approximately 0.15 log units after twelve weeks of
intervention. This increase in MPOD is almost twice as high as the changes observed in
the current study at two more central loci. If MPOD does increase more in central loci
relative to peripheral loci (e.g., Hammond et al., 1997a), then one might expect that
changes in MPOD at 20' and 30' eccentricity in the current project should have exceeded
those o f Landrum et al. (1997). The difference in effect size is difficult to reconcile given
the similarities between the two studies (e.g., MPOD measured with HFP). However,
one difference between the studies was the eccentricity of the reference measure of
sensation luminance. In the current study, the extrafoveal measure was obtained at
seven-degrees eccentricity, whereas Landrum et al. (1997) obtained a measure at eightdegrees eccentricity. Although it seems unlikely, if the mean MPOD of subjects in the
current study increased 0.07 at six degrees eccentricity, then their veridical increase in
MPOD would be about the same as Landrum et al.’s (1997) subjects. A more plausible
explanation is that the four individuals in the current project may be “average”
responders, whereas Landrum et al.’s (1997) two subjects maybe “over” responders, like
the one described by Hammond et al. (1997a).
Taken together, the results of the various intervention studies suggest that lutein
intervention, with either natural sources or supplements, can increase MPOD
approximately 0.10 log units at loci inside one-degree eccentricity. While MPOD
appears to increase more in some subjects relative to other responders, a few subjects do
not appear to respond to intervention. In addition to the aforementioned dietary factors
that affect lutein bioavailability, a few factors may limit the effects of lutein intervention
on MPOD. As previously mentioned, the duration o f lutein intervention may affect
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changes in MPOD. If MPOD does not increase during the first three to four weeks of
intervention, as reported by Landrum et al. (1997), it is not surprising that studies with
short intervention periods failed to observe a significant change in MPOD (e.g., Lariviere
et al., 2002; Cardinault et al., 2003). Another possible limiting factor may be a subject’s
baseline MPOD. Assuming the retina has a limited number of binding sites for
carotenoids, it seems logical that individuals with high MPOD have fewer free binding
sites than individuals with low MPOD. Thus, one might expect that an individual with
low MPOD might respond more to intervention than an individual with high MPOD. In
the current project, however, the increases in MPOD were the same for subject AW, who
had a baseline MPOD o f 0.51 at 30' eccentricity, and subject LS, who had a baseline
MPOD of 0.15 at this eccentricity. The independence of baseline MPOD and subsequent
increases in MPOD was also noted by Bone et al. (2003). A related limiting factor may
be the ceiling effects observed in some studies. Hammond et al. (1997a), for example,
found that MPOD appeared to plateau after four weeks of intervention, despite an
additional month o f dietary modification. It may be that retinal lutein and zeaxanthin
have a saturation point, such that concentrations beyond this threshold fail to yield
measurable increases in MPOD. In an in vitro model, Junghans et al. (2001) showed that
as the lutein or zeaxanthin concentration in liposomes increased, light transmission
through the medium decreased exponentially and eventually asymptotes. One might
assume that such a saturation effect might not only affect measures of MPOD in an
intervention study, but also PP.
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Macular Pigment Optical Density and Photophobia
The results of the current project suggest that MPOD plays a role in PP
thresholds. In Experiment One, there was a significant linear relationship between PP
ratio and MPOD at 20', 30' and 60' eccentricity. Individuals with higher MPOD at these
loci required more SW light, relative to MW light, to experience PP in the fovea. In other
words, the amount of SW light filtered by subjects’ MP was directly proportional to their
PP ratios. The relationship between SW light absorption at 20' eccentricity and PP ratio
was such that a ten-percent change in light transmission resulted in a 0.07 change in PP
ratio. The correlation between PP ratio and MPOD was strongest for the 20' locus.
Typically, individuals with high MPOD at central loci tend to have higher aggregate
totals of MP. This relationship was true for nine of the ten subjects in Experiment One.
The one subject who did not fit the correlation had relatively high MPOD at 60' and 120'
eccentricity, compared to his MPOD at 20'. Such individuals demonstrate that measures
of MPOD at a single locus cannot accurately estimate aggregate MP (Aleman et al.,
2001; Robson et al., 2003). In fact, this subject’s MPOD at 20' eccentricity was the third
lowest in the sample, but his integrated MPOD was approximately the same as the
subject with the highest MPOD at 20' eccentricity. Given the similarity in total MP
screening for these two subjects, it is not surprising that they had similar PP ratios. A
similar instance was noted by Stringham et al. (2004). In their study, two individuals had
distinctly different MPOD profiles, but almost identical iLMPOD and PP thresholds.
This finding supports the idea that PP thresholds are affected by the aggregate screening
of MP across the fovea (Stringham et al., 2003; 2004). Indeed, the correlations between
PP ratio and iGMPOD and iLMPOD are stronger than the relationships between PP ratio
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and MPOD at any single locus. This difference in the strength of the correlation would
undoubtedly be larger if the sample contained more individuals with broad or mesokurtic
MPOD profiles. Still, the significant correlations between PP ratio and MPOD suggest
that these two phenomena are related.
In Experiment Two, repeated measures of MPOD and PP ratio were obtained
during an intervention with lutein supplements. After twelve-weeks of supplementation,
MPOD at the three central loci, as well as iGMPOD and iLMPOD, significantly
increased from baseline. The significant mean increase in SW light absorption resulted in
a significant increase in mean PP ratio. This finding suggests that MP can affect PP
thresholds for lights composed of wavelengths within its absorption spectrum. The
relationship between increases in integrated MPOD and PP ratio was such that each tenpercent increase in integrated MPOD corresponded to a 0.05 increase in PP ratio. In
terms o f supplementation, a 0.05 increase in PP ratio was observed after subjects
consumed a total o f l,260mg of lutein. When the data from Experiment Two are added
to the bivariate correlations in Experiment One, the strength of the relationship between
PP ratio and iGMPOD (p < 0.0001) and iLMPOD (p < 0.0001) increases, although the
additional eight data points are not independent measures. The function observed in
Experiment One predicated the changes in PP ratio observed in Experiment Two. Thus,
Experiment Two not only upheld the correlation measured in Experiment One, but
demonstrated that MP may affect PP thresholds for SW lights.
The results o f the current project may be relevant to some clinical conditions. As
stated in the Introduction, PP is a common symptom of migraine headaches. The
prevalence of recurrent migraine headaches may be as high as eighteen-percent of the
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population, and studies report that between 50 and 100 percent o f patients experience PP
(Vanagaite et al., 1997; Krymchantowski and Moreira 2001; Wober-Bingol et al., 2004 ).
Lutein supplementation, or increased MP, may not prevent episodes of PP, but it may
increase patients’ PP thresholds, allowing them to function (with visual comfort) under a
broader range o f light intensities. Certain eye diseases, such as AMD and cataract, are
also associated with an increased incidence of PP. Lutein supplementation, then, may be
beneficial for some patients to not only preserve ocular health, but increase PP
thresholds. Relatedly, Olmedilla et al. (2001) showed that lutein supplementation (9mg
per week) significantly improved glare thresholds in patients with cataract. The patient’s
increased consumption o f lutein likely increased their MP, attenuating the amount of SW
light contributing to their glare thresholds post-treatment, relative to baseline. The post
treatment glare thresholds were measured after an average of twenty months of
intervention. One noteworthy finding in the current project was that PP thresholds could
be significantly increased in less than three months. The collective results of Olmedilla
et al. (2001) and the current project suggest that lutein supplementation may augment
MP, and thereby increase thresholds of visual discomfort in patients.
Stringham et al. (2003) proposed that PP acts as an inherent mechanism to protect
the retina from potentially dangerous levels of light. This postulation was predicated on
their finding that PP thresholds were inversely related to wavelength, as is energy, and
appeared to parallel the retinal damage function measured by Ham et al. (1976). Their
inference seems reasonable, as one would expect a photo-protective mechanism to be
biased towards more damaging wavelengths of light. Additionally, one might expect that
PP magnitude, or degree of visual discomfort, might be correlated with the intensity of
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the light source. This assumption is based on the idea that some lights, while
discomforting, may pose less risk for damage than more intense lights. In the former
instance, an adequate photo-protective response may be a moderate squint, whereas the
latter instance might require a large squint or eye closure. In the studies performed by
Stringham et al. (2003,2004), some lights exceeded the 4:1 signal-to-noise ratio criterion
for PP. Similarly, Deaver et al. (1996) showed that the length of the palpebral fissure
was inversely related to luminance. These findings are further supported by measures of
visual discomfort using scaling techniques (Sivak et al., 1999). If the magnitude or
threshold of visual discomfort is affected by light intensity, as these studies suggest, it
follows that an intervening filter should influence visual discomfort thresholds. In
outdoor environments, for example, sunglasses may reduce visual discomfort or squint
magnitude (Sliney, 2002). Likewise, the current project demonstrates that a SW filter,
the MP, attenuates PP for SW lights. The results of Stringham et al. (2004) suggest that
MP also affects thresholds for broad-band targets containing SW light (Stringham et al.,
2004). Given the influence of MP on PP, it may be that these two phenomena operate
jointly to protect the retina from excessive levels of light. The MP may act as a static
mechanism, constantly screening light in the more harmful range of the visible spectrum,
whereas PP may act as a dynamic mechanism, occurring when retinal illuminance
reaches or exceeds a certain risk threshold. In addition to protecting the retina from
potential light-induced damage, MP and PP may act to mitigate transitory deficits of
vision caused by afterimages. One anecdotal observation made by Stringham and
colleagues in their research on PP (but not yet reported) was that SW lights tended to
produce much longer afterimages than MW and LW lights containing less energy.

60

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER IX

FUTURE DIRECTIONS

The results o f the current project connected two phenomena that scientists have
been investigating separately for more than a century. Still, numerous factors associated
with MP and PP are unrealized. If MP improves visual function in diseased eyes or can
inhibit the progression of retinal degeneration, it is important to determine the dose of
carotenoids and intervention duration necessary to affect visual performance or reduce
one’s risk for AMD. This issue is particularly important in light of the growing number
o f commercially available lutein supplements and the lack of a Food and Drug
Administration Recommended Daily Allowance for lutein and zeaxanthin. If the retinal
carotenoids are conditionally essential for the health of the macula (Semba & Dagnelie,
2003), it is also important to determine why some individuals have extremely low
MPOD, and relatedly, why some individuals show no retinal response to lutein
intervention. These individuals may be at greater risk for developing macular disease.
The symptomatology o f AMD, as well as several other age-related eye diseases,
includes PP. Yet, most research investigating the clinical aspects of PP has focused on its
prevalence in patients with migraines or neurological disorders. Using the methodology
in the current project, it would be valuable to investigate the effects of lutein intervention
on PP thresholds in a clinical sample. If the results of such a study are similar to the
current project’s findings, lutein supplementation may be beneficial for individuals with
frequent episodes of PP.
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Research investigating the stimulus conditions that induce PP might also be
useful. If SW light is more likely to induce PP than MW or LW light, then an individual
with frequent episodes o f PP might benefit from using household lighting devoid o f SW
light. Unfortunately, previous researchers, except for Stringham et al. (2003; 2004),
failed to control or quantify retinal illuminance in their studies of the stimulus conditions
that affect PP thresholds. Thus, it may be beneficial to retest some of their hypotheses
using Maxwellian view optics. Additionally, several other conditions that might
influence PP thresholds, such as the eye’s state of adaptation, are unexplored.
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CHAPTER X

CONCLUSION

Numerous studies suggest that retinal lutein and zeaxanthin, or MP, may play a
role in retinal health and visual performance. The antioxidant properties of the retinal
carotenoids may attenuate oxidative stress, while the absorbency of MP may mitigate
light stress and concurrently reduce chromatic aberration. The light filtering properties of
MP also appear to influence visual comfort. Specifically, the current project
demonstrated that the MP increases the amount of light necessary to induce visual
discomfort, or PP for SW targets. Should this prove beneficial, it has been demonstrated
that twelve weeks of lutein supplementation can significantly increase MPOD, and as a
result, PP thresholds.
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CHAPTER XIII

APPENDIX A

Table 1. Age, Sex, BMI and MPOD of Experiment One subjects.
MPOD
Subject

Sex

Age

BMI

20'

30'

60'

120'

JPS

male

24

25.5

0.476

0.400

0.204

0.013

LS

female

27

19.6

0.209

0.152

0.101

0.032

JMS

male

32

24.4

0.354

0.258

0.179

0.016

AW

male

30

22.6

0.656

0.513

0.195

0.056

MW

female

29

21.3

0.415

0.314

0.213

0.126

MV

female

21

22.2

0.569

0.397

0.199

0.065

ML

male

29

29.6

0.410

0.376

0.260

0.101

CF

female

26

20.0

0.143

0.059

0.061

0.077

SB

female

21

26.6

0.513

0.394

0.230

0.019

BJ

female

26

24.1

0.483

0.401

0.216

0.145

mean

26.5

23.6

0.423

0.326

0.186

0.065

SD

3.68

3.10

0.156

0.135

0.060

0.047

CV

13.8

13.1

36.8

41.4

32.2

72.3
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Table 2. Lutein Intervention Studies that Measured MPOD in normal subjects.

Study1

#of
Subjects

Lutein Dose
Per Day

Intervention
(weeks)

Retinal Loci
Measured

Mean Change
in MPOD2

P

A3

10

11.2mg

15

30'

0.11

<0.05

B

2

30mg

20

45'

0.23

< 0.005

C4

8

lOmg

12

1.5° field

0.01

<0.001

D3

7

11.2mg

15

30'

0.07

<0.05

E

8

20mg

26

20'
30'
60'
120'

0.07
0.01
0.03
0

0.04
0.53
0.11
0.79

F

4

20mg

26

20'
30'
60'
120'

0.09
nr
nr
nr

0.002
0.56
0.35
0.66

G5

7

6mg

4

20'
30'
60'
120'

nr
nr
nr
nr

nr
nr
nr
nr

H6

21

2.4mg

26

45'

0.04

<0.05

I4' 5
J3

29

9mg

5

2° field

nr

nr

6

214gg7

12

30'

0.11

<0.04

1 Study: A, Hammond et al (1997a); B, Landrum et al (1997); C, Berendschot et al (2000); D, Johnson et al
(2000); E, Aleman et al (2001); F, Duncan et al (2002); G, Lariviere et al (2002); H, Bone et al (2003); I,
Cardinault et al (2003); J, Curran-Celentano et al (2003)
2 nr = not reported.
3 Used a natural source o f lutein (A, D: spinach + com; J: eggs), all other studies used lutein supplements.
4 Measured MPOD with reflectometry, yielding an average MPOD across a foveal area.
5 No significant change in MPOD at any eccentricity was observed.
6 Significant increases in MPOD were only observed for 12 o f the 21 subjects.
7 Calculated daily average o f consuming six eggs per week.
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University o f New Hampshire Institutional Review Board approval letter.

UNIVERSITY o f N E W HA M P SH IR E

July 23, 2004
W enzel, Adam
Psychology, C onant Hall
25A E. Concord, Apt. # 3
Dover, NH 03820

IRB # :
2990
Study:
Im p act of Macular Pigm ent on
Approval Date: 07/24/2003

Photophobia

T he Institutional Review Board for th e Protection o f Human S ubjects in R esearch (IRB)
h as review ed and approved th e protocol for your study a s Expedited a s described in
Title 4 5, Code of Federal Regulations (CFR), P art 46, Subsection 110.

Approval is granted to conduct your study as described in your protocol for
one year from the approval date above. At th e end of th e approval period, you will
b e asked to subm it a report with regard to th e involvem ent of hum an su b jects in this
study. If your study is still active, you m ay re q u e st a n extension o f IRB approval.
R esearchers w ho conduct studies involving hum an subjects have responsibilities a s
outlined in th e attach ed docum ent, Responsibilities of Directors of Research Studies
Involving Human Subjects.
(This
docum ent
is
also
available
at
http://w w w .unh.edu/osr/com oliance/IR B .htm l.') Please read this docu m en t carefully
before com m encing your w ork involving hum an subjects.
If you h ave questions o r concerns a b o u t your study o r this approval, please feel free to
co n tact m e a t 603-862-2003 or Julie.sim pson@ unh.edu. P lease refe r to th e IRB #
above in all correspondence related to this study. T he IRB w ishes you success with your
research.

For th e IRB,
^

y

i

k

l

-

f

f y

M anager
cc:

File
K enneth Fuld

Research Conduct and Compliance Services, Office of Sponsored Research, Service
Building, 51 College Road, Durham, NH 03824-3585 * Fax: 603-862-3564
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